2012 | Ketan T. Savjani, Anuradha K. Gajjar, and Jignasa K. Savjani
Drug solubility is crucial for achieving the desired concentration of a drug in systemic circulation for effective pharmacological response. Poor solubility is a major challenge in the formulation of new chemical entities (NCEs) and generic drugs, with over 40% of NCEs being practically insoluble in water. Solubility enhancement techniques are essential for improving drug absorption and bioavailability, especially for poorly soluble drugs. These techniques include physical modifications like particle size reduction, chemical modifications such as salt formation and complexation, and other methods like solid dispersions, nanosuspensions, and inclusion complexes.
Particle size reduction increases the surface area-to-volume ratio, enhancing solubility. Techniques such as micronization, solid dispersions, and nanosuspensions are effective in improving solubility. Solid dispersions use hydrophilic carriers to enhance dissolution, while nanosuspensions utilize surfactants to stabilize nano-sized drug particles. Cryogenic techniques produce nanostructured amorphous particles with high porosity, improving solubility. Inclusion complex formation with cyclodextrins enhances solubility by encapsulating hydrophobic drugs in a hydrophobic cavity.
Micellar solubilization uses surfactants to increase the solubility of poorly soluble drugs by forming micelles that trap the drug. Hydrotrophy involves adding hydrotropic agents to increase the solubility of a drug in water. Crystal engineering techniques, such as controlling crystallization conditions, can produce polymorphs with improved solubility and dissolution rates. Cocrystals formed between a drug and a cocrystal former also enhance solubility and bioavailability.
Various methods, including supercritical fluid (SCF) processes, high-pressure homogenization, and cryogenic techniques, are used to enhance solubility. These methods are critical for improving the bioavailability and therapeutic efficacy of poorly soluble drugs, especially for oral and parenteral administration. The selection of solubility enhancement techniques depends on drug properties, dosage form requirements, and regulatory considerations. Effective solubility enhancement ensures better patient compliance, reduced dosing frequency, and improved therapeutic outcomes.Drug solubility is crucial for achieving the desired concentration of a drug in systemic circulation for effective pharmacological response. Poor solubility is a major challenge in the formulation of new chemical entities (NCEs) and generic drugs, with over 40% of NCEs being practically insoluble in water. Solubility enhancement techniques are essential for improving drug absorption and bioavailability, especially for poorly soluble drugs. These techniques include physical modifications like particle size reduction, chemical modifications such as salt formation and complexation, and other methods like solid dispersions, nanosuspensions, and inclusion complexes.
Particle size reduction increases the surface area-to-volume ratio, enhancing solubility. Techniques such as micronization, solid dispersions, and nanosuspensions are effective in improving solubility. Solid dispersions use hydrophilic carriers to enhance dissolution, while nanosuspensions utilize surfactants to stabilize nano-sized drug particles. Cryogenic techniques produce nanostructured amorphous particles with high porosity, improving solubility. Inclusion complex formation with cyclodextrins enhances solubility by encapsulating hydrophobic drugs in a hydrophobic cavity.
Micellar solubilization uses surfactants to increase the solubility of poorly soluble drugs by forming micelles that trap the drug. Hydrotrophy involves adding hydrotropic agents to increase the solubility of a drug in water. Crystal engineering techniques, such as controlling crystallization conditions, can produce polymorphs with improved solubility and dissolution rates. Cocrystals formed between a drug and a cocrystal former also enhance solubility and bioavailability.
Various methods, including supercritical fluid (SCF) processes, high-pressure homogenization, and cryogenic techniques, are used to enhance solubility. These methods are critical for improving the bioavailability and therapeutic efficacy of poorly soluble drugs, especially for oral and parenteral administration. The selection of solubility enhancement techniques depends on drug properties, dosage form requirements, and regulatory considerations. Effective solubility enhancement ensures better patient compliance, reduced dosing frequency, and improved therapeutic outcomes.